openPR Logo
Press release

Metagenomics Sequencing Market worth USD 2564.01 million by 2027

12-14-2021 04:14 PM CET | IT, New Media & Software

Press release from: Market Statsville Group

Metagenomics Sequencing Market worth USD 2564.01 million

The Market Statsville Group (MSG) publishes the new report on the "Metagenomics Sequencing Market by Product & Services (Reagents & Consumables, Instruments, and Services (Analysis & Data Interpretation Solutions and Metagenomic Sequencing Services)), by Technology (16S rRNA Sequencing, Whole Genome Sequencing & De Novo Assembly, Shotgun Metagenomics Sequencing, and Metatranscriptomics), by Application (Ecological & Environmental Metagenomics, Clinical Diagnostics, Drug Discovery, Biofuel, and Industrial Applications), by Region – Global Share and Forecast to 2027".

The global metagenomics sequencing market size is expected to grow from USD 974.3 million in 2020 to USD 2564.01 million by 2027, at a CAGR of 17.5% during the forecast period. Metagenomics plays a vital role in the genomic field; besides applying metagenomics in biocatalysts from nature, it also has found applications in fields as diverse as bioremediation, ecological & environmental metagenomics, clinical diagnostic, drug discovery, and industrial application. Clinical diagnostic metagenomics enables pathogen detection by unbiased next-generation sequencing. Recently, metagenomic sequencing and bioinformatics technology have increased the adoption of precision diagnostic tests based on metagenomics sequencing. In addition, the DNA extracted from the desired organism then purified, cloned, and expressed in a heterologous host such as function-based screenings can be useful for discovering novel proteins such as antibiotics. Hence, such various applications supplement the market growth.

Browse 211 market data Tables and 63 Figures spread through 234 Pages and in-depth TOC on "Metagenomics Sequencing Market Research Report 2021-2027."

Get Free Sample Report:

Global Metagenomics Sequencing Market Segmentation
The overall metagenomics sequencing market has been segmented into product & services, technology, application, and region.

By Product & Services Outlook (Sales, USD Million, 2017-2027)
• Reagents & Consumables
• Instruments
• Services
o Analysis & Data Interpretation Solutions
o Metagenomic Sequencing Services

By Technology Outlook (Sales, USD Million, 2017-2027)
• Shotgun Metagenomics Sequencing
• 16S rRNA Sequencing
• Whole Genome Sequencing & De Novo Assembly
• Metatranscriptomics

By Application Outlook (Sales, USD Million, 2017-2027)
• Drug Discovery
• Ecological & Environmental Metagenomics
• Clinical Diagnostics
• Biofuel
• Industrial Applications

By Region Outlook (Sales, USD Million, 2017-2027)
• North America (US, Canada, Mexico)
• South America (Brazil, Argentina, Colombia, Peru, Rest of Latin America)
• Europe (Germany, Italy, France, UK, Spain, Poland, Russia, Slovenia, Slovakia, Hungary, Czech Republic, Belgium, the Netherlands, Norway, Sweden, Denmark, Rest of Europe)
• Asia Pacific (China, Japan, India, South Korea, Indonesia, Malaysia, Thailand, Vietnam, Myanmar, Cambodia, the Philippines, Singapore, Australia & New Zealand, Rest of Asia Pacific)
• The Middle East & Africa (Saudi Arabia, UAE, South Africa, Northern Africa, Rest of MEA)

Buy Now at 25% discount:

Shotgun metagenomic sequencing, by technology, is estimated to hold the largest market share during the forecast period
By technology, the global metagenomic sequencing market is categorized into shotgun metagenomics sequencing, 16S rRNA sequencing, whole-genome sequencing & de novo assembly, and metatranscriptomics. In 2020, shotgun metagenomic sequencing accounted for the largest market, with a 30.2% market share. The shotgun metagenomic sequencing segment is expected to showcase lucrative market growth during the forecast period. Factors such as advantages offered by shotgun sequencing are better than other technologies, growth in the adoption and preference toward shotgun metagenomic sequencing among researchers & healthcare professionals, and the surge in the number of metagenomic sequencing-based research activities are anticipated to propel the growth of the industry.

The rise in preference toward adopting shotguns due to better advantages is anticipated to help the global metagenomics sequencing market gain traction. Since the past few years, shotgun metagenomic sequencing has increased due to the application where all the genomes in DNA can be read with the help of shotgun metagenomic sequencing. There has been an increase in the number of product launches accomplished by players with shotgun metagenomic sequencing, which is expected to help the market generate higher revenue from this segment.

Don't miss out on business opportunities in Metagenomics Sequencing Market. Speak to our research analyst and gain crucial market insights to grow your business.

North America accounts for the largest market share in the metagenomic sequencing market 2020
The global metagenomics sequencing market has been segmented across North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. In 2020, North America accounted for the highest market share of 42.3% in the global metagenomics sequencing market and was anticipated to maintain its dominance throughout the forecast period. Stronghold on Deoxyribonucleic Acid (DNA) sequencing technologies due to the continuous improvement, availability, and accessibility of DNA sequencing in North America. Several global manufacturers of DNA sequencing, platforms, equipment, and technologies are highly active in North America, especially in the U.S. For instance, key market players, such as Illumina, Inc., Thermo Fisher Scientific Inc., and others, have their corporate presence in this region. Hence, most DNA sequencing products and platforms are first launched in the U.S. and then distributed to other world regions.

The key market players strive to introduce affordable DNA sequencing technologies in North America. This has provided momentum to the global metagenomics market in this region, enabling further investigation of microbial ecology. Moreover, the North American market has witnessed tremendous developments regarding the utilization of metagenomics products and technologies in biotechnology, which are expected to make way for new avenues and provide numerous growth opportunities for the expansion of the market.

This research report covers an analysis of the major firms' development and marketing tactics and a study of their product portfolios and winning methods in the plastic bottles and containers industry. Illumina, Inc., Macrogen Inc., BGI Genomics Co., Ltd., Eurofins Genomics, Oxford Nanopore Technologies Ltd, QIAGEN N.V., Swift Biosciences Inc., Pacific Biosciences of California, Inc., Thermo Fisher Scientific Inc., and PerkinElmer Inc. are among the prominent businesses represented. Each firm pursues its own business plan to gain a major market share.

Browse complete report:

Contact Us:
Market Statsville Group
416, East Standsberry Street, Perkins, Oklahoma 74059, USA
USA: +1-580-205-2707 | +91 702 496 8807

Content Source:

About Market Statsville Group
Market Statsville Group (MSG) is a business research and consulting platform of Statsville Consulting Private Limited, based in Oklahoma, USA. MSG is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in market sizing, analysis, and intelligent business insights. MSG has experienced research analysts who are proficient at digging deep and providing various customizable data that help you make decisions with clarity, confidence, and impact. Furthermore, Market Statsville Group already benefited more than 1,000 companies each year for their revenue planning. It helped them take their disruptions/innovations early to the market by providing them research ahead of the curve.
MSG has an entire repository of research reports on more than 1,000 niche industries, 3,000 high-growth potentials markets, 5,000 data sets, and more than 12,000 company profiles.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Metagenomics Sequencing Market worth USD 2564.01 million by 2027 here

News-ID: 2498281 • Views: 274

More Releases from Market Statsville Group

Autonomous Driving Software Market size is expected to grow at a CAGR of 29.5% f …
A new study titled "Autonomous Driving Software Market Size 2022", published by Market Statsville Group (MSG), provides information on regional and global markets. MSG expects the global Autonomous Driving Software market will showcase an impressive CAGR from 2022 to 2030. The comprehensive research report on the Autonomous Driving Software market offers valuable insights, shedding light on the market dynamics, value chain analysis, regulatory framework, emerging investment hotspots, competitive landscape, regional
Remote Sensing Technology Market Size, Share, Growth, Up-To-Date Key Outlook, an …
A new study titled "Remote Sensing Technology Market Size 2022", published by Market Statsville Group (MSG), provides information on regional and global markets. MSG expects the global Remote Sensing Technology market will showcase an impressive CAGR from 2022 to 2030. The comprehensive research report on the Remote Sensing Technology market offers valuable insights, shedding light on the market dynamics, value chain analysis, regulatory framework, emerging investment hotspots, competitive landscape, regional
Influencer Marketing Platform Market Worth US$ 251157.78 million by 2033
According to the Market Statsville Group (MSG), the global influencer marketing platform market size is expected to grow from USD 13548.56 million in 2022 to USD 251157.78 million by 2033, at a CAGR of 30.4% from 2023 to 2033. The study report covers crucial data on growth strategy, innovations, market dynamics, company profiles, and market competitiveness for 2022. The Influencer Marketing Platform market report guides new entrants or key existing
Smart Vehicle Control Unit Market size is expected at a CAGR of 7.6% from 2022 t …
A new study titled "Smart Vehicle Control Unit Market Size 2022", published by Market Statsville Group (MSG), provides information on regional and global markets. MSG expects the global Smart Vehicle Control Unit market will showcase an impressive CAGR from 2022 to 2030. The comprehensive research report on the Smart Vehicle Control Unit market offers valuable insights, shedding light on the market dynamics, value chain analysis, regulatory framework, emerging investment hotspots,

All 5 Releases

More Releases for Sequencing

Next Generation Sequencing Market Growth of Technological Advancements in Sequen …
Research Report on Next Generation Sequencing Market providing Global Industry Scenario for 5 years (2019 to 2026) is now available under the Life Sciences Section of Get Research Sample PDF at Global Next Generation Sequencing Market Trends, Competitive Analysis and Forecast Report 2018-2026 is an exhaustive study on the present market scenario of the global Next Generation Sequencing industry with a special focus on the United States, Europe,
Metagenomic Sequencing Market Technology Outlook 2027 - 16s Rrna Sequencing, Sho …
Worldwide Metagenomic Sequencing Market Analysis to 2027 is a specialized and in-depth study of the Metagenomic Sequencing Industry with a focus on the global market trend. The report aims to provide an overview of global Metagenomic Sequencing Market with detailed market segmentation by product/application and geography. The global Metagenomic Sequencing Market is expected to witness high growth during the forecast period. Metagenomics, is a field where genomic analysis of microbial DNA
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may
Precision Medicine Market Report 2018: Segmentation by Technology (Genomics, Tra …
Global Precision Medicine market research report provides company profile for Abbott Laboratories, Almac Group, Ltd, Asuragen, Inc., Cepheid Inc, Cetics Healthcare Technologies GmbH, Ge Healthcare, Glaxosmithkline Plc, Intomics A/S., Biocrates Life Sciences Ag, Pfizer Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Next Generation Sequencing (NGS) Market, By Technology (Whole Exon Sequencing (W …
The next generation sequencing market is estimated to represent a global market of USD 5,618 million by 2017 with growth rate of 9.1%. Next-generation sequencing (NGS) involves an advanced level of genetic sequencing which is a level above the conventional methods such as capillary electrophoresis-based Sanger sequencing. NGS procedure is a multi-step process where a number of smaller laboratory processes combine to form the whole next-generation sequencing process. This includes
Next Generation Sequencing Market Global Analysis and Forecasts by Service (Geno … has announced the addition of the “Next Generation Sequencing Market to 2025”, the report classifies the global Next Generation Sequencing Market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth. The next generation market is estimated to account for US$ 26,501.2 Mn by the end of 2025, escalating at a CAGR of 21.1% during the